[{"address1": "14/15 Conduit Street", "city": "London", "zip": "W1S 2XJ", "country": "United Kingdom", "phone": "44 20 7495 2379", "website": "https://www.tizianalifesciences.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Tiziana Life Sciences Ltd, a biotechnology company, engages in the development of transformative therapies for neurodegenerative and lung diseases in the United States. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for use in the treatment of Crohn's, graft versus host, ulcerative colitis, multiple sclerosis, type-1 diabetes, inflammatory bowel, psoriasis, and rheumatoid arthritis diseases. It is also developing TZLS-501, a fully human mAb targeting the IL-6 receptor for use in the treatment of inflammatory and oncology indications. Tiziana Life Sciences Ltd was incorporated in 1998 and is headquartered in London, the United Kingdom.", "fullTimeEmployees": 9, "companyOfficers": [{"maxAge": 1, "name": "Mr. Gabriele Marco Antonio Cerrone M.B.A.", "age": 52, "title": "Founder & Executive Chairman", "yearBorn": 1972, "fiscalYear": 2024, "totalPay": 1853000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Ivor R. Elrifi Ph.D.", "title": "CEO & Executive Director", "fiscalYear": 2024, "totalPay": 131000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Keeren  Shah", "age": 48, "title": "COO & CFO", "yearBorn": 1976, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Napoleone  Ferrara M.D.", "age": 67, "title": "Member of Scientific Advisory Board", "yearBorn": 1957, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.0, "open": 2.04, "dayLow": 1.92, "dayHigh": 2.09, "regularMarketPreviousClose": 2.0, "regularMarketOpen": 2.04, "regularMarketDayLow": 1.92, "regularMarketDayHigh": 2.09, "payoutRatio": 0.0, "beta": 0.242, "forwardPE": -39.4, "volume": 268096, "regularMarketVolume": 268096, "averageVolume": 398285, "averageVolume10days": 454140, "averageDailyVolume10Day": 454140, "bid": 1.93, "ask": 2.0, "bidSize": 2, "askSize": 2, "marketCap": 230190032, "fiftyTwoWeekLow": 0.63, "fiftyTwoWeekHigh": 2.6, "allTimeHigh": 12.17, "allTimeLow": 0.41, "fiftyDayAverage": 1.9596, "twoHundredDayAverage": 1.373, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 215963360, "profitMargins": 0.0, "floatShares": 63394363, "sharesOutstanding": 116847732, "sharesShort": 1108870, "sharesShortPriorMonth": 657243, "sharesShortPreviousMonthDate": 1755216000, "dateShortInterest": 1757894400, "sharesPercentSharesOut": 0.0095, "heldPercentInsiders": 0.43061, "heldPercentInstitutions": 0.04138, "shortRatio": 3.1, "shortPercentOfFloat": 0.0143, "impliedSharesOutstanding": 127334067, "bookValue": 0.035, "priceToBook": 56.285713, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -11863000, "trailingEps": -0.11, "forwardEps": -0.05, "lastSplitFactor": "2499:1000", "lastSplitDate": 1596153600, "enterpriseToEbitda": -13.684, "52WeekChange": 1.1413043, "SandP52WeekChange": 0.17904854, "quoteType": "EQUITY", "currentPrice": 1.97, "targetHighPrice": 8.017094, "targetLowPrice": 8.017094, "targetMeanPrice": 8.017094, "targetMedianPrice": 8.017094, "recommendationMean": 1.0, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 1, "totalCash": 3724000, "totalCashPerShare": 0.033, "ebitda": -15782000, "totalDebt": 106000, "quickRatio": 1.002, "currentRatio": 1.022, "debtToEquity": 2.693, "returnOnAssets": -0.84125, "returnOnEquity": -2.50486, "freeCashflow": -588250, "operatingCashflow": -1526000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "TLSA", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "postMarketTime": 1759527147, "regularMarketTime": 1759521600, "regularMarketChangePercent": -1.5, "regularMarketPrice": 1.97, "marketState": "CLOSED", "postMarketChangePercent": 3.5533, "postMarketPrice": 2.04, "postMarketChange": 0.0699999, "regularMarketChange": -0.03, "regularMarketDayRange": "1.92 - 2.09", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 398285, "fiftyTwoWeekLowChange": 1.34, "fiftyTwoWeekLowChangePercent": 2.1269841, "fiftyTwoWeekRange": "0.63 - 2.6", "fiftyTwoWeekHighChange": -0.6299999, "fiftyTwoWeekHighChangePercent": -0.24230765, "fiftyTwoWeekChangePercent": 114.130424, "earningsTimestampStart": 1750708800, "earningsTimestampEnd": 1752004800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.11, "epsForward": -0.05, "epsCurrentYear": -0.134, "priceEpsCurrentYear": -14.701492, "fiftyDayAverageChange": 0.010400057, "fiftyDayAverageChangePercent": 0.005307235, "twoHundredDayAverageChange": 0.597, "twoHundredDayAverageChangePercent": 0.43481427, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Tiziana Life Sciences PLC", "nameChangeDate": "2025-10-02", "averageAnalystRating": "1.0 - Strong Buy", "cryptoTradeable": false, "corporateActions": [], "exchange": "NCM", "messageBoardId": "finmb_261234197", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1542724200000, "shortName": "Tiziana Life Sciences Ltd", "longName": "Tiziana Life Sciences Ltd", "displayName": "Tiziana Life Sciences", "trailingPegRatio": null, "__fetch_time": "2025-10-04"}]